DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 108 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,320 | +2.7% | 2,308,028 | -0.1% | 0.00% | 0.0% |
| Q2 2023 | $27,579 | +23.9% | 2,309,731 | +38.7% | 0.00% | +33.3% |
| Q1 2023 | $22,259 | -52.6% | 1,664,751 | -23.7% | 0.00% | -62.5% |
| Q4 2022 | $46,969 | -99.9% | 2,182,578 | +4.2% | 0.01% | +14.3% |
| Q3 2022 | $41,962,000 | +14.8% | 2,094,913 | +2.6% | 0.01% | +40.0% |
| Q2 2022 | $36,540,000 | +132.3% | 2,041,344 | +28.7% | 0.01% | +150.0% |
| Q1 2022 | $15,731,000 | -40.9% | 1,585,741 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $26,639,000 | -23.6% | 1,580,978 | +5.0% | 0.00% | -33.3% |
| Q3 2021 | $34,865,000 | +4.3% | 1,506,326 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $33,434,000 | – | 1,505,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |